An increased visceral-subcutaneous adipose tissue ratio is associated with difficult-to-treat hypertension in men

Journal of Hypertension

Volumn 28, Issue 6, 2010, Pages 1140-1146

  Ishikawa, Joji ^a   Haimoto, Hajime ^a   Hoshide, Satoshi ^a   Eguchi, Kazuo ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a NONE

Author keywords

Difficult to treat hypertension; Metabolic syndrome; Visceral adipose tissue

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL;

EID: 77952501224     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328338158b     Document Type: Article

References (27)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant Hypertension: diagnosis, evaluation, and treatment - a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510-e526.
2. Calhoun DA. Resistant or difficult-to-treat hypertension. J Clin Hypertens (Greenwich) 2006; 8:181-186.
3. Moser M, Setaro JF. Resistant or difficult-to-control hypertension. N Engl J Med 2006; 355:385-392.
4. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52:1749-1757.
5. Tykarski A. Resistant hypertension. Blood Press 2005; 14(Suppl 2):42-45.
6. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27:2276-2283.
7. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116:39-48.
8. Koiwaya Y. Definition and criterion of metabolic syndrome [in Japanese]. Jpn J Clin Exp Med 2007; 84:99-103.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
10. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB. Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit 1998; 3:261-265.
11. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, et al. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26:771-782.
12. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
13. Mezzetti A, Pierdomenico SD, Costantini F, Romano F, Bucci A, Gioacchino MD, Cuccurullo F. White-coat resistant hypertension. Am J Hypertens 1997; 10:1302-1307.
14. Orr JS, Gentile CL, Davy BM, Davy KP. Large artery stiffening with weight gain in humans: role of visceral fat accumulation. Hypertension 2008; 51:1519-1524.
15. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med 2008; 86:729-734.
16. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, et al. GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in nondiabetic people in China: a dietary intervention study. Lancet 2009; 373:829-835.
17. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 2006; 24:1633-1639.
18. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 2002; 39:982-988.
19. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168:1159-1164.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation 2005; 112:2735-2752.
21. Wildman RP, Gu D, Muntner P, Huang G, Chen J, Duan X, He J. Alcohol intake and hypertension subtypes in Chinese men. J Hypertens 2005; 23:737-743.
22. Soardo G, Donnini D, Varutti R, Milocco C, Basan L, Esposito W, et al. Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers. J Hypertens 2006; 24:1493-1498.
23. Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, et al. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 2009; 53:13-19.
24. Ishikawa J, Kario K, Hoshide S, Eguchi K, Morinari M, Kaneda R, et al. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens 2005; 18:958-965.
25. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 2008; 52:1-6.
26. Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension 2008; 52:865-872.
27. Tank J, Heusser K, Diedrich A, Hering D, Luft FC, Busjahn A, et al. Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab 2008; 93:4974-4978.